Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer
Sònia Palomeras(Universitat de Girona), Teresa Puig(IrsiCaixa)
Cited by 72
Related Papers
Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer
|BMC Cancer|2012|101
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
|PLoS ONE|2015|67
(−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
|Molecules|2018|45